Skip to main content

Corporate insider profile

Christopher M Starr Insider Trades

Latest reported as Corporate insider of Monopar Therapeutics (MNPR).

Purchase filings
0
Reported companies
1
Net open-market value
-$659,386.56
Latest transaction
Oct 1, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 1, 2026Monopar Therapeutics (MNPR)Corporate insiderSale8,400$78.50$659,387